Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design

(2017) Ineke A. van Rossum et al.   JOURNAL OF ALZHEIMERS DISEASE

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers

(2011) Niklas Mattsson et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us

(2011) Nina F. Schor   ANNALS OF NEUROLOGY

Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative

(2011) Lon S. Schneider   ARCHIVES OF NEUROLOGY

IAGG Workshop: Health promotion program on prevention of late onset dementia

(2011) S. Andrieu et al.   Journal of Nutrition Health & Aging

APOE modifies the association between A  load and cognition in cognitively normal older adults

(2011) K. Kantarci et al.   NEUROLOGY

Ethical considerations of biomarker use in neurodegenerative diseases—A case study of Alzheimer's disease

(2011) David Prvulovic et al.   PROGRESS IN NEUROBIOLOGY

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

(2011) Michael Ewers et al.   TRENDS IN NEUROSCIENCES

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

(2010) Harald Hampel et al.   NATURE REVIEWS DRUG DISCOVERY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Biomarkers for Alzheimer's disease therapeutic trials

(2010) Harald Hampel et al.   PROGRESS IN NEUROBIOLOGY

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” A national registry to identify a cohort for Alzheimer's disease prevention studies

(2009) Marwan N. Sabbagh et al.   Alzheimers & Dementia

Alzheimer's Disease Anti-Inflammatory Prevention Trial: Design, methods, and baseline results

(2009)   Alzheimers & Dementia

Ginkgo biloba for Preventing Cognitive Decline in Older AdultsA Randomized Trial

(2009) Beth E. Snitz   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

(2009) S. Salloway et al.   NEUROLOGY

Dementia Prevention: Methodological Explanations for Inconsistent Results

(2008) N. Coley et al.   EPIDEMIOLOGIC REVIEWS